1-hydroxymethylmidazolam has been researched along with bilirubin in 2 studies
Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (bilirubin) | Trials (bilirubin) | Recent Studies (post-2010) (bilirubin) |
---|---|---|---|---|---|
163 | 46 | 49 | 25,921 | 1,337 | 5,871 |
Protein | Taxonomy | 1-hydroxymethylmidazolam (IC50) | bilirubin (IC50) |
---|---|---|---|
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3884 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.3183 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Goh, BC; Hee, KH; Lee, LS; Sapari, NS; Seng, KY; Soon, GH; Soong, R | 1 |
Gościniak, K; Grabowski, T; Sopata, M; Stachowiak-Szymczak, K; Teżyk, A; Zaporowska-Stachowiak, I | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and bilirubin
Article | Year |
---|---|
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.
Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic | 2014 |
1 other study(ies) available for 1-hydroxymethylmidazolam and bilirubin
Article | Year |
---|---|
Midazolam and hydroxymidazolam plasma concentrations can be monitored with selected biochemical and physiological parameters of palliative care patients.
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers; Body Mass Index; Creatinine; Drug Dosage Calculations; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Models, Biological; Palliative Care; Pilot Projects; Reproducibility of Results | 2021 |